当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Oumer Abdu Muhie
Objective: This review is concerned on coronavirus disease (COVID-19) pandemic that is affecting the globe. The aim of this update is to summarize the up-to-date knowledge about the virus, its way of transmission, clinical features, diagnosis, and treatment.
Result: COVID-19 is a public health threat affecting humankind currently after the emergence and spread of the novel coronavirus or the severe acute respiratory syndrome coronavirus 2. The virus is believed to have originated from bats and transmitted to humans. Around 8.5 million peoples are confirmed to have the COVID-19 and more than 450 000 individuals have died of it by June 18, 2020, all over the world. It is transmitted by inhaling or having contact with droplets. The incubation period ranges from 2- 14 days. It manifests mainly with fever, nonproductive cough, and dyspnea. Polymerase chain reaction from various samples like throat swabs, nasal swabs, bronchoalveolar lavage fluid is used to confirm the diagnosis. High-resolution chest computerized tomography is abnormal in most patients and typical findings are ground glass patchy opacities on both lungs and sub-segmental consolidation. Treatment is largely supportive. The battle of developing vaccines that can halt COVID-19 Pandemic is ongoing and some of those are to be tested in phase III trials. Remdesivir, an antiviral was found to shorten recovery time of COVID-19 patients in preliminary result of a trial. Dexamethasone was found to reduce mortality by one-third among seriously sick COVID-19 patients requiring mechanical ventilation.